Quality-adjusted life-years gain and health status in patients with OSAS after one year of continuous positive airway pressure use

Sleep

Volumn 37, Issue 12, 2014, Pages 1963-1968

  Rizzi, Camila F ^a   Ferraz, Marcos B ^a   Poyares, Dalva ^a   Tufik, Sergio ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CPAP; Obstructive sleep apnea (OSA); Quality adjusted life years (QALY); Utility

Indexed keywords

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BRAZIL; CLINICAL EVALUATION; DIASTOLIC BLOOD PRESSURE; EPWORTH SLEEPINESS SCALE; FEMALE; HEALTH STATUS; HUMAN; INTERVENTION STUDY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; SHORT FORM 6 DIMENSION; SLEEP DISORDERED BREATHING; SLEEP MEDICINE; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; HEALTH SURVEY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SLEEP; SLEEP APNEA, OBSTRUCTIVE; TIME; TREATMENT OUTCOME; UTILIZATION;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; BRAZIL; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; SLEEP; SLEEP APNEA, OBSTRUCTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84914132629     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4250     Document Type: Article

References (36)

1. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008;52:686-717.
2. Ellen RL, Marshall SC, Palayew M, Molnar FJ, Wilson KG, Man-Son-Hing M. Systematic review of motor vehicle crash risk in persons with sleep apnea. J Clin Sleep Med 2006;2:193-200.
3. Aloia MS, Arnedt JT, Smith L, Skrekas J, Stanchina M, Millman RP. Examining the construct of depression in obstructive sleep apnea syndrome. Sleep Med 2005;6:115-21.
4. Bano K, Kryger MH. Sleep apnea: clinical investigations in humans. Sleep Med 2007;8:400-26.
5. Chervin RD. Sleepiness, fatigue, tiredness, and lack of energy in obstructive sleep apnea. Chest 2000;118:372-9.
6. Siccoli MM, Pepperell JC, Kohler M, Craig SE, Davies RJ, Stradling JR. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep 2008;31:1551-8.
7. Sánchez AI, Martínez P, Miró E, Bardwell WA, Buela-Casal G. CPAP and behavioral therapies in patients with obstructive sleep apnea: effects on daytime sleepiness, mood, and cognitive function. Sleep Med Rev 2009;13:223-33.
8. Albarrak M, Banno K, Sabbagh AA, et al. Utilization of healthcare resources in obstructive sleep apnea syndrome: a 5-year follow-up study in men using CPAP. Sleep 2005;28:1306-11.
9. Leger D, Bayon V, Laaban JP, Philip P. Impact of sleep apnea on economics. Sleep Med Rev 2012;16:455-62.
10. Robinson R. Economic evaluation and health care. What does it mean? BMJ 1993;307:670-3.
11. Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 1998;51:1115-28.
12. Ayas NT, FitzGerald JM, Fleetham JA, et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med 2006;166:977-84.
13. Tan MC, Ayas NT, Mulgrew A, et al. Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia. Can Respir J 2008;15:159-65.
14. Mar J, Rueda JR, Durán-Cantolla J, Schechter C, Chilcott J. The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. Eur Respir J 2003;21:515-22.
15. Chobanian AV, Bakris GL, Black WR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-72.
16. Iber C, Ancoli-Israel S, Chesson A, Quan S, for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, 1st ed. Westchester, IL: American Academy of Sleep Medicine, 2007.
17. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005;28:499-521.
18. Obradovic M, Lal A, Liedgens H. Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health Qual Life Outcomes 2013;11:110.
19. Campolina AG, Bortoluzzo AB, Ferraz MB, Ciconelli RM. Validation of the Brazilian version of the generic six-dimensional short form quality of life questionnaire (SF-6D Brazil). Cien Saude Colet 2011;16:3103-10.
20. Cruz LN, Camey SA, Hoffmann JF, et al. Estimating the SF-6D value set for a population-based sample of Brazilians. Value Health 2011;14:S108-14.
21. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92.
22. Teckle P, McTaggart-Cowan H, Van der Hoek K, et al. Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D. Health Qual Life Outcomes 2013;11:203.
23. Schmidlin M, Fritsch K, Matthews F, Thurnheer R, Senn O, Bloch KE. Utility indices in patients with the obstructive sleep apnea syndrome. Respiration 2010;79:200-8.
24. Billings ME, Kapur VK. Medicare long-term CPAP coverage policy: a cost-utility analysis. J Clin Sleep Med 2013;9:1023-9.
25. Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep 2004;27:453-8.
26. Hoffman B, Wingenbach DD, Kagey AN, Schaneman JL, Kasper D. The long-term health plan and disability cost benefit of obstructive sleep apnea treatment in a commercial motor vehicle driver population. J Occup Environ Med 2010;52:473-7.
27. Montesi SB, Edwards BA, Malhotra A, Bakker JP. The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med 2012;8:587-96.
28. Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 2007;30:711-9.
29. Sobocki P, Ekman M, Ovanfors A, Khandker R, Jönsson B. The costutility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder. Int J Clin Pract 2008;62:623-32.
30. Eriksson MK, Hagberg L, Lindholm L, Malmgren-Olsson EB, Osterlind J, Eliasson M. Quality of life and cost-effectiveness of a 3-year trial of lifestyle intervention in primary health care. Arch Intern Med 2010;170:1470-9.
31. Botteman MF, Ozminkowski RJ, Wang S, Pashos CL, Schaefer K, Foley DJ. Cost effectiveness of long-term treatment with eszoplicone for primary insomnia: a decision analytical model. CNS Drugs 2007;21:319-34.
32. Price D, Asukai Y, Ananthapavan J, Malcolm B, Radwan A, Keyzor I. A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use. Appl Health Econ Health Policy 2013;11:259-74.
33. Hettle R, Wouters H, Ayres J, et al. Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium. Respir Med 2012;106:1722-33.
34. Menn P, Leidl R, Holle R. A lifetime Markov model for the economic evaluation of chronic obstructive pulmonary disease. Pharmacoeconomics 2012;30:825-40.
35. Athanasakis K, Souliotis K, Tountas Y, Kyriopoulos J, Hatzakis A. A cost-utility analysis of hypertension treatment in Greece: assessing the impact of age, sex, smoking status, on outcomes. J Hypertens 2012;30:227-34.
36. Barbé F, Durán-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010;181:718-26.